Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 300-08-3
2. Arecoline Hbr
3. Taeniolin
4. Arecoline Bromide
5. Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate Hydrobromide
6. Arecoline (hydrobromide)
7. Mfcd00039041
8. Nsc-31750
9. 24s79b9cx7
10. Methyl 1-methyl-3,6-dihydro-2h-pyridine-5-carboxylate,hydrobromide
11. Mls000028840
12. Arekolinhydrobromid
13. Arekolinhydrobromid [german]
14. Nsc31750
15. Sr-01000075307
16. Smr000058258
17. Einecs 206-087-3
18. Nsc 31750
19. Arecoline Hydrobromide [nf]
20. Esterase
21. Unii-24s79b9cx7
22. Prestwick_958
23. Oleyllinoleate
24. Methyl 1,2,5,6-tetrahydro-1-methylnicotinate Hydrobromide
25. Methyl N-methyl-1,2,5,6-tetrahydronicotinate Hydrobromide
26. N-methyltetrahydronicotinic Acid Methyl Ester Hydrobromide
27. Methyl 1,2,5,6-tetrahydro-1-methylnicotinate, Hydrobromide
28. 3-pyridinecarboxylic Acid, 1,2,5,6-tetrahydro-1-methyl-, Methyl Ester, Hydrobromide
29. Areciline Hydrochloride,(s)
30. Mls002222282
31. Arecoline, Hydrobromide
32. Schembl527735
33. Spectrum1500680
34. Chembl449209
35. Dtxsid9075379
36. Hms1569a06
37. Hms1921c10
38. Pharmakon1600-01500680
39. Arecoline Hydrobromide [mi]
40. Bcp02923
41. Hy-b0489
42. Tox21_500049
43. 3-pyridinecarboxylicacid, 1,2,5,6-tetrahydro-1-methyl-, Methyl Ester
44. Ccg-38354
45. Nsc757418
46. S2614
47. Akos009031332
48. Ac-8048
49. Bcp9000314
50. Lp00049
51. Nsc-757418
52. Ps-7647
53. 3-pyridinecarboxylicacid, 1,2,5,6-tetrahydro-1-methyl-, Methyl Ester, Hydrobromide
54. Nicotinic Acid, 1,2,5,6-tetrahydro-1-methyl-, Methyl Ester, Hydrobromide
55. Wln: T6n Cutj A1 Cvo1 & Gh
56. Ncgc00093563-01
57. Ncgc00093563-02
58. Ncgc00093563-03
59. Ncgc00093563-04
60. Ncgc00093563-05
61. Ncgc00093563-06
62. Ncgc00260734-01
63. Sy057191
64. Bcp0726000295
65. A0523
66. Am20090404
67. Eu-0100049
68. Ft-0628354
69. Ft-0662274
70. Sw197045-3
71. A 6134
72. Q-100382
73. Sr-01000075307-1
74. Sr-01000075307-3
75. Sr-01000075307-8
76. Q27253878
77. Sr-01000075307-10
78. Sr-01000075307-11
79. Methyl N-methyl-1,5,6-tetrahydronicotinate Hydrobromide
80. Arecoline Hydrobromide, Vetranal(tm), Analytical Standard
81. Methyl 1,5,6-tetrahydro-1-methylnicotinate, Hydrobromide
82. Nicotinic Acid,2,5,6-tetrahydro-1-methyl-, Methyl Ester, Hydrobromide
83. 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylic Acid Methyl Ester Hydrobromide
84. 3-pyridinecarboxylic Acid,2,5,6-tetrahydro-1-methyl-, Methyl Ester, Hydrobromide
85. 7-amino-3-hydroxymethyl-3-cephem-4-carbonsaeure-gamma-lacton--p-toluolsulfat
| Molecular Weight | 236.11 g/mol |
|---|---|
| Molecular Formula | C8H14BrNO2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 235.02079 g/mol |
| Monoisotopic Mass | 235.02079 g/mol |
| Topological Polar Surface Area | 29.5 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 187 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3415
Submission : 1978-12-14
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3415
Submission : 1978-12-14
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Arecoline Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Arecoline Hydrobromide, including repackagers and relabelers. The FDA regulates Arecoline Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Arecoline Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Arecoline Hydrobromide supplier is an individual or a company that provides Arecoline Hydrobromide active pharmaceutical ingredient (API) or Arecoline Hydrobromide finished formulations upon request. The Arecoline Hydrobromide suppliers may include Arecoline Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Arecoline Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Arecoline Hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Arecoline Hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Arecoline Hydrobromide DMFs exist exist since differing nations have different regulations, such as Arecoline Hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Arecoline Hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Arecoline Hydrobromide USDMF includes data on Arecoline Hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Arecoline Hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Arecoline Hydrobromide suppliers with USDMF on PharmaCompass.
Arecoline Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Arecoline Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Arecoline Hydrobromide GMP manufacturer or Arecoline Hydrobromide GMP API supplier for your needs.
A Arecoline Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Arecoline Hydrobromide's compliance with Arecoline Hydrobromide specifications and serves as a tool for batch-level quality control.
Arecoline Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Arecoline Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Arecoline Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Arecoline Hydrobromide EP), Arecoline Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Arecoline Hydrobromide USP).
LOOKING FOR A SUPPLIER?
